American James Allison and Japan’s Tasuku Honjo have won the 2018 Nobel Prize in Medicine for a pioneering approach to cancer treatment.
Dr. Allison and Dr. Honjo, working separately, showed in the 1990s how certain proteins act as “brakes” on the immune system’s T-cells, limiting their ability to attack cancer cells, and that suppressing those proteins could transform the body’s ability to fight cancer.
All previous types of cancer therapy were directed at the tumor cell, but Allison’s and Honjo’s approach was to remove brakes that keep the immune system in check, unleashing it against tumor cells. These “checkpoint inhibitor” therapies have greatly increased survival of cancer patients and may produce even greater results when combined with traditional therapies.
“The seminal discoveries by the two Laureates constitute a landmark in our fight against cancer,” the Nobel Assembly at Sweden’s Karolinska Institute said as it awarded the prize of nine million Swedish crowns ($1 million). The treatments, often referred to as “immune checkpoint therapy”, have “fundamentally changed the outcome for certain groups of patients with advanced cancer”, it added.
Post Your Comments